Denali Therapeutics Down After Proposing To Sell $250 Million Of Shares

On:

Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.

The company today said it proposes offer for sale of $250 million of shares.

DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.

Source: Read Full Article

Lates News:
  1. Green Dot Corp. Drops 10% As Profit, Revenue Decline In Q2
  2. Quoin Pharmaceuticals Up 28% On Plans To Start Second Trial To Evaluate QRX003 Topical Lotion
  3. 65% Of Bitcoin Supply Unmoved In Over A Year, Signaling Bottom And Looming Upwards Price Action
  4. Cryptos Plummet Amidst A Dollar That Leaps On Fed Fears
  5. London Stock Exchange To Offer Clearing Of Bitcoin Futures And Options